BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Minikes AM, Song Y, Feng Y, Yoon C, Yoon SS, Jiang X. E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene 2023;42:848-57. [PMID: 36717701 DOI: 10.1038/s41388-023-02599-5] [Reference Citation Analysis]
2 Tapak L, Ghasemi MK, Afshar S, Mahjub H, Soltanian A, Khotanlou H. Identification of gene profiles related to the development of oral cancer using a deep learning technique. BMC Med Genomics 2023;16:35. [PMID: 36849997 DOI: 10.1186/s12920-023-01462-6] [Reference Citation Analysis]
3 Bereza M, Dembiński M, Zając AE, Piątkowski J, Dudzisz-Śledź M, Rutkowski P, Czarnecka AM. Epigenetic Abnormalities in Chondrosarcoma. Int J Mol Sci 2023;24. [PMID: 36901967 DOI: 10.3390/ijms24054539] [Reference Citation Analysis]
4 Cui S, Feng J, Tang X, Lou S, Guo W, Xiao X, Li S, Chen X, Huan Y, Zhou Y, Xiao L. The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients. Eur J Med Res 2023;28:90. [PMID: 36805828 DOI: 10.1186/s40001-023-01058-x] [Reference Citation Analysis]
5 Javed A, Yarmohammadi M, Korkmaz KS, Rubio-Tomás T. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. Int J Mol Sci 2023;24. [PMID: 36769170 DOI: 10.3390/ijms24032848] [Reference Citation Analysis]
6 Benesch MGK, Mathieson A, O'Brien SBL. Effects of Tumor Localization, Age, and Stage on the Outcomes of Gastric and Colorectal Signet Ring Cell Adenocarcinomas. Cancers (Basel) 2023;15. [PMID: 36765680 DOI: 10.3390/cancers15030714] [Reference Citation Analysis]
7 Ivanova M, Sajjadi E, Zattoni L, Fusco N. HER2 Testing in Breast and Gastric Cancer with CDH1 Germline Mutations. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_10] [Reference Citation Analysis]
8 Jing W, Cao Y, Wang H, Qian D. E-cadherin and FGFR3 are risk factors determining prognosis of patients with bladder urothelial carcinoma. Am J Transl Res 2023;15:1510-6. [PMID: 36915751] [Reference Citation Analysis]
9 de Assumpção PB, de Assumpção PP, Moreira FC, Ribeiro-Dos-Santos Â, Vidal AF, Magalhães L, Khayat AS, Ribeiro-Dos-Santos AM, Cavalcante GC, Pereira AL, Medeiros I, de Souza SJ, Burbano RMR, de Souza JES, Dos Santos SEB. Incidence of Hereditary Gastric Cancer May Be Much Higher than Reported. Cancers (Basel) 2022;14. [PMID: 36551612 DOI: 10.3390/cancers14246125] [Reference Citation Analysis]
10 Malpeli G, Barbi S, Innamorati G, Alloggio M, Filippini F, Decimo I, Castelli C, Perris R, Bencivenga M. Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. J Pers Med 2022;12. [PMID: 36556227 DOI: 10.3390/jpm12122006] [Reference Citation Analysis]
11 Coudert M, Drouet Y, Delhomelle H, Svrcek M, Benusiglio PR, Coulet F, Clark DF, Katona BW, van Hest LP, van der Kolk LE, Cats A, van Dieren JM, Nehoray B, Slavin T, Spier I, Hüneburg R, Lobo S, Oliveira C, Boussemart L, Masson L, Chiesa J, Schwartz M, Buecher B, Golmard L, Bouvier AM, Bonadona V, Stoppa-Lyonnet D, Lasset C, Colas C. First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants. J Med Genet 2022;59:1189-95. [PMID: 36038258 DOI: 10.1136/jmg-2022-108740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol 2022;86:566-82. [PMID: 34933124 DOI: 10.1016/j.semcancer.2021.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Luo R. CircRNA circ-MYBL2 absorbs precursor miR-92b in the nucleus to suppress its role in enhancing gastric cancer cell proliferation. Am J Med Sci 2022;364:454-60. [PMID: 35644224 DOI: 10.1016/j.amjms.2022.05.022] [Reference Citation Analysis]
14 Cerrato-izaguirre D, Chirino YI, Prada D, Quezada-maldonado EM, Herrera LA, Hernández-guerrero A, Alonso-larraga JO, Herrera-goepfert R, Oñate-ocaña LF, Cantú-de-león D, Meneses-garcía A, Basurto-lozada P, Robles-espinoza CD, Camacho J, García-cuellar CM, Sánchez-pérez Y. Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma. IJMS 2022;23:11116. [DOI: 10.3390/ijms231911116] [Reference Citation Analysis]
15 Zheng H, Xue H, E Y, Cui Z. The oncogenic roles of John Cunningham virus T antigen in digestive epithelial cells with tissue specificity.. [DOI: 10.21203/rs.3.rs-1927120/v1] [Reference Citation Analysis]
16 Rath S, Chakraborty D, Pradhan J, Imran Khan M, Dandapat J. Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy. Cytokine 2022;157:155967. [PMID: 35905624 DOI: 10.1016/j.cyto.2022.155967] [Reference Citation Analysis]
17 Gu C, Xie L, Li B, Zhang L, Li F, Wang W, Su J, Xu Z. Quantification of Tumor Abnormal Proteins in the Diagnosis and Postoperative Prognostic Evaluation of Gastric Cancer. Clin Med Insights Oncol 2022;16:11795549221104440. [PMID: 35774594 DOI: 10.1177/11795549221104440] [Reference Citation Analysis]
18 Choi YJ, Kim B, Kim Y, Shin S, Lee K. Applying Functional Assay Evidence to Interpret Sequence Variants Identified in Hereditary Cancer Genes. Lab Med Online 2022;12:145-158. [DOI: 10.47429/lmo.2022.12.3.145] [Reference Citation Analysis]
19 Kovalenko NV, Zhavoronkova VV, Postolov MP, Suvorov VA. Hereditary diffuse gastric cancer syndrome: medical genetic consulting, treatment strategy for family members, prophylactic total gastrectomy, and endoscopic surveillance in CDH1- and CTNNA1-mutation carriers. Sib onkol ž 2022;21:126-134. [DOI: 10.21294/1814-4861-2022-21-3-126-134] [Reference Citation Analysis]
20 Kuroki M, Shibata H, Kuze B, Ohashi T, Kohyama K, Kato H, Kato H, Miyazaki T, Tomita H, Ogawa T. Genetic Panel Test of Double Cancer of Signet-Ring Cell/Histiocytoid Carcinoma of the Eyelid and Papillary Thyroid Carcinoma: Case Report and Literature Review. Cureus 2022. [DOI: 10.7759/cureus.25192] [Reference Citation Analysis]
21 Chen G, Jia G, Chao F, Xie F, Zhang Y, Hou C, Huang Y, Tang H, Yu J, Zhang J, Jia S, Xu G. Urine- and Blood-Based Molecular Profiling of Human Prostate Cancer. Front Oncol 2022;12:759791. [DOI: 10.3389/fonc.2022.759791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Fang Y, Cao H, Gong X, Chen Y, Zhuang Y, Zhou S, Chen Y, Jiang Y, Ji X, Peng H, Jing X. AFF4 Predicts the Prognosis of Colorectal Cancer Patients and Suppresses Colorectal Cancer Metastasis via Promoting CDH1 Expression. Front Oncol 2022;12:797392. [PMID: 35223479 DOI: 10.3389/fonc.2022.797392] [Reference Citation Analysis]
23 De Re V, Alessandrini L, Brisotto G, Caggiari L, De Zorzi M, Casarotto M, Miolo G, Puglisi F, Garattini SK, Lonardi S, Cannizzaro R, Canzonieri V, Fassan M, Steffan A. HER2-CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients' Survival in HER2-Positive Metastatic Gastric Adenocarcinoma. Cancers (Basel) 2022;14:1266. [PMID: 35267574 DOI: 10.3390/cancers14051266] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gong Y, Jiao Y, Qi X, Fu J, Qian J, Zhu J, Yang H, Tang L. Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02503-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Islam MR, Alam MK, Paul BK, Koundal D, Zaguia A, Ahmed K, Teekaraman Y. Identification of Molecular Biomarkers and Key Pathways for Esophageal Carcinoma (EsC): A Bioinformatics Approach. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/5908402] [Reference Citation Analysis]
26 Kiseleva A, Zezyulina A, Mikerova M, Bykov I, Reshetov I. Clinical value of CDH1 gene in gastric cancer. Onkol Z im P A Gercena 2022;11:74. [DOI: 10.17116/onkolog20221102174] [Reference Citation Analysis]
27 Luxenburger A, Bougen-Zhukov N, Fraser MG, Beetham H, Harris LD, Schmidt D, Cameron SA, Guilford PJ, Evans GB. Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer. J Med Chem 2021;64:18114-42. [PMID: 34878770 DOI: 10.1021/acs.jmedchem.1c01609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Rubtsova SN, Zhitnyak IY, Gloushankova NA. Dual role of E-cadherin in cancer cells. Tissue Barriers 2021;:2005420. [PMID: 34821540 DOI: 10.1080/21688370.2021.2005420] [Reference Citation Analysis]
29 Meng K, Cao J, Dong Y, Zhang M, Ji C, Wang X. Application of Bioinformatics Analysis to Identify Important Pathways and Hub Genes in Ovarian Cancer Affected by WT1. Front Bioeng Biotechnol 2021;9:741051. [PMID: 34692659 DOI: 10.3389/fbioe.2021.741051] [Reference Citation Analysis]
30 Sremac M, Paic F, Grubelic Ravic K, Serman L, Pavicic Dujmovic A, Brcic I, Krznaric Z, Nikuseva Martic T. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma. Oncol Lett 2021;22:822. [PMID: 34691249 DOI: 10.3892/ol.2021.13083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Okamoto K, Kodama M, Mizukami K, Okimoto T, Abe H, Ogawa R, Fukuda K, Matsunari O, Hirashita Y, Wada Y, Fukuda M, Murakami K. Immunohistochemical differences in gastric mucosal damage between nodular and non-nodular gastritis caused by Helicobacter pylori infection. J Clin Biochem Nutr 2021;69:216-21. [PMID: 34616112 DOI: 10.3164/jcbn.20-179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Van Herck Y, Feyaerts A, Alibhai S, Papamichael D, Decoster L, Lambrechts Y, Pinchuk M, Bechter O, Herrera-caceres J, Bibeau F, Desmedt C, Hatse S, Wildiers H. Is cancer biology different in older patients? The Lancet Healthy Longevity 2021;2:e663-77. [DOI: 10.1016/s2666-7568(21)00179-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
33 Zhao Z, Li S, Li S, Wang J, Lin H, Fu W. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer. Cancer Cell Int 2021;21:493. [PMID: 34530820 DOI: 10.1186/s12935-021-02071-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Hemminki K, Sundquist K, Sundquist J, Försti A, Hemminki A, Li X. Familial Risks and Proportions Describing Population Landscape of Familial Cancer. Cancers (Basel) 2021;13:4385. [PMID: 34503195 DOI: 10.3390/cancers13174385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
36 Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki A, Hemminki K. Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer. Clin Epidemiol 2021;13:515-25. [PMID: 34239328 DOI: 10.2147/CLEP.S304332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
38 Dang DNT, Nguyen HTT, Ngo HD, Tran BM, Vu AD, Dang HQ, Ta VT. A novel stop codon mutation in exon 5 (c.639G>A) of the cadherin-1 gene in a Vietnamese man with hereditary diffuse gastric cancer: a case report. J Med Case Rep 2021;15:263. [PMID: 33941229 DOI: 10.1186/s13256-021-02837-y] [Reference Citation Analysis]
39 Wan XM, Zhou XL, Du YJ, Shen H, Yang Z, Ding Y. TASP1 Promotes Proliferation and Migration in Gastric Cancer via EMT and AKT/P-AKT Pathway. J Immunol Res 2021;2021:5521325. [PMID: 34012990 DOI: 10.1155/2021/5521325] [Reference Citation Analysis]
40 Zheng L, Zhan Y, Lu J, Hu J, Kong D. A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer. Ann Transl Med 2021;9:680. [PMID: 33987378 DOI: 10.21037/atm-21-1010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Cao S, Wang Y, Li J, Ling X, Zhang Y, Zhou Y, Zhong H. Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer. Front Oncol 2021;11:587744. [PMID: 33828969 DOI: 10.3389/fonc.2021.587744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ishioka M, Yoshio T, Miyamoto Y, Namikawa K, Tokai Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Fujisaki J. Incidence of metachronous cancer after endoscopic submucosal dissection: a comparison between undifferentiated-type and differentiated-type early gastric cancer. Gastrointest Endosc 2021;93:557-564.e1. [PMID: 32621817 DOI: 10.1016/j.gie.2020.06.067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 Yelskaya Z, Arnold AG, Marcell VJ, Tang LH, Salo-Mullen EE, Strong VE, Stadler ZK, Zhang L. Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant. Eur J Hum Genet 2021;29:1103-9. [PMID: 33619332 DOI: 10.1038/s41431-021-00825-w] [Reference Citation Analysis]
44 Swanson E, Jedrzkiewicz J, Wang HL, Samowitz W. Carcinomas of the Gastrointestinal Tract. Practical Gastrointestinal Pathology 2021. [DOI: 10.1007/978-3-030-51268-2_18] [Reference Citation Analysis]
45 Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, Alessandrini L, Canzonieri V, Miolo G, Puglisi F, Belluco C, Steffan A, Cannizzaro R. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options. Int J Mol Sci 2020;21:E9400. [PMID: 33321820 DOI: 10.3390/ijms21249400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
46 Kasochi C, Julius P, Mweemba I, Kayamba V. Human epidermal growth factor receptor 2 overexpression in gastric and gastroesophageal junction adenocarcinoma in patients seen at the University Teaching Hospital, Lusaka, Zambia. Afr Health Sci 2020;20:1857-64. [PMID: 34394249 DOI: 10.4314/ahs.v20i4.41] [Reference Citation Analysis]
47 Takano H, Shibata T, Nakamura M, Sakurai N, Hayashi T, Ota M, Nomura-Horita T, Hayashi R, Shimasaki T, Otsuka T, Tahara T, Arisawa T. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa. BMC Med Genet 2020;21:205. [PMID: 33066747 DOI: 10.1186/s12881-020-01142-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Goud HK, Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Rutkofsky IH. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review. Cureus 2020;12:e10406. [PMID: 33062523 DOI: 10.7759/cureus.10406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
49 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
50 Niemeyer E, Mofid H, Zornig C, Burandt EC, Stein A, Block A, Volk AE. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family. BMC Gastroenterol 2020;20:129. [PMID: 32362280 DOI: 10.1186/s12876-020-01283-2] [Reference Citation Analysis]